Preliminary assessment of a neuropathic pain treatment and referral algorithm for patients with cancer.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Journal of Pain and Symptom Management

• Publication date

  2011-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.jpainsymman.2011.03.017PMID 21820851
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment.

  2010cited by this paper
• Anticonvulsant drugs for acute and chronic pain.

  2010cited by this paper
• Anticonvulsant drugs for acute and chronic pain.

  2010cited by this paper
• Gender differences in risk factors for aberrant prescription opioid use.

  2010cited by this paper
• Nortriptyline and gabapentin, alone and in combination for neuropathic pain: a double-blind, randomised controlled crossover trial.

  2009cited by this paper
• A treatment algorithm for neuropathic pain: an update.

  2009cited by this paper
• The Brief Pain Inventory User Guide

  2009cited by this paper
• Using quality improvement methodology to improve neuropathic pain screening and assessment in patients with cancer

  2009cited by this paper
• Does pain mediate the pain interference with sleep problem in chronic pain? Findings from studies for management of diabetic peripheral neuropathic pain with duloxetine.

  2008cited by this paper
• Incidence rates and treatment of neuropathic pain conditions in the general population☆

  2008cited by this paper
• Pharmacologic management of neuropathic pain: Evidence‐based recommendations

  2007cited by this paper
• Antidepressants for neuropathic pain.

  2007cited by this paper
• Morphine, nortriptyline and their combination vs. placebo in patients with chronic lumbar root pain

  2007cited by this paper
• Background Noise: The Experience of Chemotherapy-Induced Peripheral Neuropathy

  2007cited by this paper
• Genetic architecture of human pain perception.

  2007cited by this paper
• Methadone for cancer pain.

  2007cited by this paper
• Duloxetine for patients with diabetic peripheral neuropathic pain: a 6-month open-label safety study.

  2006cited by this paper
• Catechol‐O‐methyltransferase gene polymorphisms are associated with multiple pain‐evoking stimuli

  2006cited by this paper
• Tramadol for neuropathic pain.

  2006cited by this paper
• Methadone for cancer-related neuropathic pain: a review of the literature.

  2006cited by this paper
• Difficult Pain Syndromes: Bone Pain, Visceral Pain, and Neuropathic Pain

  2006cited by this paper
• Algorithm for neuropathic pain treatment: An evidence based proposal

  2005cited by this paper
• Gabapentin is Effective in the Treatment of Cancer-Related Neuropathic Pain: A Prospective, Open-Label Studya,b

  2005cited by this paper
• The Val158Met polymorphism of the human catechol‐O‐methyltransferase (COMT) gene may influence morphine requirements in cancer pain patients

  2005cited by this paper
• Efficacy of pregabalin in neuropathic pain evaluated in a 12‐week, randomised, double‐blind, multicentre, placebo‐controlled trial of flexible‐ and fixed‐dose regimens

  2005cited by this paper
• Burden of illness in painful diabetic peripheral neuropathy: the patients' perspectives.

  2005cited by this paper
• Morphine, gabapentin, or their combination for neuropathic pain.

  2005cited by this paper
• Pain severity in diabetic peripheral neuropathy is associated with patient functioning, symptom levels of anxiety and depression, and sleep.

  2005cited by this paper
• Duloxetine vs. placebo in patients with painful diabetic neuropathy

  2005cited by this paper
• Genetic basis for individual variations in pain perception and the development of a chronic pain condition.

  2005cited by this paper
• A treatment algorithm for neuropathic pain.

  2004cited by this paper
• Gabapentin for neuropathic cancer pain: a randomized controlled trial from the Gabapentin Cancer Pain Study Group.

  2004cited by this paper
• Methadone versus morphine as a first-line strong opioid for cancer pain: a randomized, double-blind study.

  2004cited by this paper
• Tramadol for neuropathic pain.

  2004cited by this paper
• Pregabalin for the treatment of postherpetic neuralgia

  2003cited by this paper
• Diagnosis and treatment of neuropathic pain.

  2003cited by this paper
• Efficacy of lidocaine patch 5% in the treatment of focal peripheral neuropathic pain syndromes: a randomized, double‐blind, placebo‐controlled study

  2003cited by this paper
• Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations.

  2003cited by this paper
• Mechanisms and management of neuropathic pain in cancer.

  2003cited by this paper
• Safety and Tolerability of the Lidocaine Patch 5%, a Targeted Peripheral Analgesic: A Review of the Literature

  2003cited by this paper
• Quality improvement of painful peripheral neuropathy.

  2002cited by this paper
• The Lidocaine Patch 5% Effectively Treats All Neuropathic Pain Qualities: Results of a Randomized, Double-Blind, Vehicle-Controlled, 3-Week Efficacy Study With Use of the Neuropathic Pain Scale

  2002cited by this paper
• Phase III evaluation of nortriptyline for alleviation of symptoms of cis‐platinum‐induced peripheral neuropathy

  2002cited by this paper
• Gabapentin and Venlafaxine for the Treatment of Painful Diabetic Neuropathy

  2001cited by this paper
• Evidence-based data on pain relief with antidepressants

  2000cited by this paper
• Psychiatric symptoms and distress differ between patients with postherpetic neuralgia and peripheral vestibular disease.

  2000cited by this paper
• Antidepressants and anticonvulsants for diabetic neuropathy and postherpetic neuralgia: a quantitative systematic review.

  2000cited by this paper
• The treatment of neuropathic pain: antidepressants and opioids.

  2000cited by this paper
• Amitriptyline and fluphenazine in the treatment of postherpetic neuralgia.

  2000cited by this paper
• Course of symptoms and quality of life measurement in Complex Regional Pain Syndrome: a pilot survey.

  2000cited by this paper
• Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action.

  1999cited by this paper
• Self efficacy as a mediator of the relationship between pain intensity, disability and depression in chronic pain patients.

  1999cited by this paper
• Efficacy of oxycodone in neuropathic pain: a randomized trial in postherpetic neuralgia.

  1998cited by this paper
• Randomized, double-blind, cross-over trial comparing safety and efficacy of oral controlled-release oxycodone with controlled-release morphine in patients with cancer pain.

  1998cited by this paper
• Neuropathic pain in the cancer patient.

  1998cited by this paper
• Neuroanatomy of the pain system and of the pathways that modulate pain.

  1997cited by this paper
• A systematic review of antidepressants in neuropathic pain

  1996cited by this paper
• Psychological Aspects of Chronic Pain and Disability

  1996cited by this paper
• Pain beliefs: assessment and utility

  1994cited by this paper
• Effect of megestrol acetate on quality of life in a dose-response trial in women with advanced breast cancer. The Cancer and Leukemia Group B.

  1993cited by this paper
• Patient‐related barriers to management of cancer pain

  1993cited by this paper
• Peripheral and central mechanisms of cutaneous hyperalgesia.

  1992cited by this paper
• A standardised scale to measure beliefs about controlling pain (B.P.C.Q.): A preliminary study

  1990cited by this paper
• Conceptualization and Measurement of Health for Adults in the Health Insurance Study

  1979cited by this paper

• Neurotoxicity in Cancer Survivorship: The Significance of Cancer-Related Cognitive Impairment and Chemotherapy-Induced Peripheral Neuropathy.

  2024cites this paper
• A qualitative analysis of algorithm-based decision support usability testing for symptom management across the trajectory of cancer care: one size does not fit all

  2024cites this paper
• Symptom Management Guideline Implementation Among Nurses in Cancer-Specific Outpatient Settings

  2024cites this paper
• Exploring social determinants of health on chemotherapy-induced peripheral neuropathy severity in ovarian cancer: An integrative review

  2024cites this paper
• Knowledge levels of oncology nurses regarding evidence-based practices in the assessment and management of chemotherapy-induced peripheral neuropathy

  2024cites this paper
• Spinal Mobilization and Manipulation in Horses.

  2022cites this paper
• Clinical decision support for symptom management in lung cancer patients: A group RCT.

  2021cites this paper
• Tetrodotoxin for Chemotherapy-Induced Neuropathic Pain: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Dose Finding Trial

  2021cites this paper
• The efficacy of gabapentin combined with opioids for neuropathic cancer pain: a meta-analysis

  2021cites this paper
• Psychometric Testing of the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire–Chemotherapy-Induced Peripheral Neuropathy 20-Item Scale Using Pooled Chemotherapy-Induced Peripheral Neuropathy Outcome Measures Standardization and Alliance for Clinical Trials in O

  2019cites this paper
• On the Road Less Traveled: Journey of an Oncology Palliative Care Researcher.

  2017cites this paper
• Emotional Responses to Persistent Chemotherapy-induced Peripheral Neuropathy Experienced by Patients with Colorectal Cancer in Japan

  2017cites this paper
• The effect of intraperitoneal chemotherapy on early pain hyperalgesia in patients following elective laparoscopic transabdominal resection of rectal cancer

  2017cites this paper
• Assessment of Multiple Co-Occurring Cancer Symptoms in the Clinical Setting.

  2016cites this paper
• Neuropathic Pain Components in Patients with Cancer: Prevalence, Treatment, and Interference with Daily Activities

  2016cites this paper
• Pain Syndromes Associated with Cancer Therapy

  2016cites this paper
• Antineuropathic Profile of N-Palmitoylethanolamine in a Rat Model of Oxaliplatin-Induced Neurotoxicity

  2015cites this paper
• Symptom management in the older adult: 2015 update.

  2015cites this paper
• What about Alice? Peripheral neuropathy from taxane-containing treatment for advanced nonsmall cell lung cancer

  2014cites this paper
• Nursing knowledge, practice patterns, and learning preferences regarding chemotherapy-induced peripheral neuropathy.

  2014cites this paper
• Review of a Study of Duloxetine for Painful Chemotherapy-Induced Peripheral Neuropathy

  2013cites this paper
• Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trial.

  2013influential citation
• Beyond Neuropathic Pain: Gabapentin Use in Cancer Pain and Perioperative Pain

  2013cites this paper
• Assessing patient-reported peripheral neuropathy: the reliability and validity of the European Organization for Research and Treatment of Cancer QLQ-CIPN20 Questionnaire

  2013cites this paper
• Peripheral Neuropathy Caused by Paclitaxel and Docetaxel: An Evaluation and Comparison of Symptoms

  2013cites this paper
• Chemotherapy-induced peripheral neuropathy: an algorithm to guide nursing management.

  2013cites this paper
• Obwodowa neuropatia wywołana chemioterapią. Część II. Zapobieganie

  2012cites this paper
• Treatment of Chemotherapy - Induced Peripheral Neuropathy: The Physicians Need Guidelines, the Patients Need Help

  2012cites this paper
• Chemotherapy-induced peripheral neuropathy. Part II. Prevention

  2012cites this paper